FDA cracks down on Hims, other telehealth companies over drug ads

Federal health officials are cracking down on telehealth companies’ promotion of unapproved versions of prescription drugs, including popular weight loss medications.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup